Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAESTRO: Comparison of Triflusal and Clopidogrel in Secondary Stroke Prevention by CYP2C19 Genotyping
KCT0000025Phase 4Active, not recruiting
- Sponsor
- Myungin Pharm
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Triflusal, clopidogrel in brain infarction, sponsored by Myungin Pharm. Started Mar 2010; status: active, not recruiting.
02
Drugs
Triflusalclopidogrel
03
Conditions
brain infarction
Beyond the preview
Go deeper on KCT0000025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000025.